FCPA Enforcement Driving Compliance Software

Last month, the DOJ's Assistant Attorney General for the Criminal Division, Lanny Breuer, gave a rousing speech putting the pharmaceutical industry on notice that it would be subject to increased enforcement of international anti-bribery statutes. Perhaps it was to be expected that what might follow would be an equally rigorous response from the private sector.

Unlock unlimited access to all Global Investigations Review content